Avalo Therapeutics, Inc. (AVTX) ownership: Top institutional holder: FMR LLC ($42.99M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 2879481.00 | $42.99M | 2026-03-31 |
| T. Rowe Price Investment Management, Inc. | 2162684.00 | $32.29M | 2026-03-31 |
| Caligan Partners LP | 1635023.00 | $24.41M | 2026-03-31 |
| BVF INC/IL | 1632845.00 | $24.38M | 2026-03-31 |
| Avoro Capital Advisors LLC | 1410000.00 | $21.05M | 2026-03-31 |
| Affinity Asset Advisors, LLC | 1340840.00 | $20.02M | 2026-03-31 |
| Nantahala Capital Management, LLC | 1235000.00 | $18.44M | 2026-03-31 |
| UBS Group AG | 1141980.00 | $17.05M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-10 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 |
Back to AVTX overview · AVTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.